The adenylate cyclase toxin (ACT) of Bordetella pertussis intoxicates target cells by generating supraphysiologic levels of intracellular cyclic AMP (cAMP). Since ACT kills macrophages rapidly and potently, we asked whether ACT would also kill neutrophils. In fact, ACT prolongs the neutrophil life span by inhibiting constitutive apoptosis and preventing apoptosis induced by exposure to live B. pertussis. Imaging of B. pertussis-exposed neutrophils revealed that B. pertussis lacking ACT induces formation of neutrophil extracellular traps (NETs), whereas wild-type B. pertussis does not, suggesting that ACT suppresses NET formation. Indeed, ACT inhibits formation of NETs by generating cAMP and consequently inhibiting the oxidative burst. Convalescent-phase serum from humans following clinical pertussis blocks the ACT-mediated suppression of NET formation. These studies provide novel insight into the phagocyte impotence caused by ACT, which not only impairs neutrophil function but also inhibits death of neutrophils by apoptosis and NETosis.
P
ertussis, or whooping cough, is the coughing syndrome caused by Bordetella pertussis. The incidence of pertussis in the United States has increased 10-fold over the last 30 years despite vaccination (1) . Addition of new antigens to the vaccine has been suggested as a solution to this resurgence (2) . A leading candidate for inclusion in future acellular vaccine formulations is the adenylate cyclase toxin (ACT) because it is essential for virulence, immunogenic, and a demonstrated protective antigen (3) (4) (5) (6) . ACT is composed of a 400-amino-acid C-terminal catalytic domain and a 1,306-amino-acid cell-binding domain that is homologous to the repeats in toxins (RTX) family of pore-forming bacterial protein toxins (7) . After ACT binds to a host cell, the catalytic domain is translocated directly across the cell membrane and converts ATP to cyclic AMP (cAMP) in a reaction enhanced by intracellular eukaryotic calmodulin (8, 9) . During this reaction, supraphysiologic levels of intracellular cAMP are produced and ATP is consumed (10, 11) . ACT exhibits noncatalytic functions, including the formation of cytolytic oligomeric pores, elicitation of potassium efflux upon membrane insertion, and stimulation of calcium influx (12) (13) (14) . These noncatalytic effects generally occur at concentrations of ACT at which cAMP elevation and ATP depletion overwhelm cellular physiology.
The first functional effects of ACT on cells were described by Confer and Eaton, who found that crude extracts of B. pertussis inhibit the oxidative burst, bacterial killing, chemotaxis, and phagocytosis of neutrophils and macrophages (15) . Subsequently, Pearson et al. showed that the inhibition of phagocyte oxidative activity and chemotaxis correlates with cAMP generation (16) . More recent studies have shown that ACT inhibits Fc-receptormediated and complement receptor-mediated phagocytosis by neutrophils and macrophages (17, 18) . In 2001, Guermonprez et al. found that ACT is most potent toward neutrophils, macrophages, and other leukocytes that express the integrin CD11b/ CD18 (CR3), ultimately identifying this surface glycoprotein as a toxin receptor (19, 20) . Exposure of J774 macrophages, which express CR3, to ACT at 30 ng/ml results in apoptotic cell death within 2 h (11, 21) .
The mechanisms of cell death in neutrophils are distinct from those of other leukocytes (22) , and the effects of ACT on neutrophil death had not previously been characterized. Several forms of programmed cell death have been described in neutrophils, but the most studied is apoptosis. Upon terminal differentiation, all neutrophils progress constitutively toward apoptotic cell death, and certain stimuli can either prolong (e.g., lipopolysaccharide [LPS] and granulocyte-macrophage colony-stimulating factor [GM-CSF]) or shorten (e.g., Fas-ligand and bacterial phagocytosis) the neutrophil life span (23) (24) (25) . In 2004, Brinkmann et al. described the formation of the neutrophil extracellular trap (NET), a novel neutrophil function that results in cell death (26) . NETs are the result of a sequence of events initiated when neutrophils are activated by certain bacteria, bacterial products, and cytokines, as well as the protein kinase C activator phorbol 12-myristate 13-acetate (PMA). After appropriate stimulation, nuclear chromatin and histones mix with cytoplasmic granule enzymes, and this web of proteins and DNA is released into the extracellular space, eventually resulting in neutrophil lysis, or "NETosis" (27) . Formation of NETs induced by many stimuli requires activation of the NADPH oxidase system (28) . Because PMA is a nonparticulate, chemical activator of the neutrophil oxidative burst and NETosis, it is commonly used to study the mechanism of NET formation. NADPH oxidase-independent NET formation has been observed in response to some stimuli, such as Staphylococcus aureus, and neutrophils exposed to S. aureus in vivo form 3-isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich) were added, and at the indicated time points, cells were stained for annexin V-Alexa Fluor 488 and propidium iodide (PI) per the Life Sciences staining kit protocol. Flow cytometry was performed on a BD FACSCalibur instrument, and analysis was performed with FlowJo software.
Caspase 3/7 measurement. A total of 2 ϫ 10 5 neutrophils were plated in a white-walled, clear-bottom, 96-well, tissue culture-treated plate. Toxin was added, and the mixture was incubated for the indicated times at 37°C in 5% CO 2 . Caspase 3/7 was measured according to the manufacturer's instructions using the Caspase-Glo 3/7 assay (Promega). The caspase 3/7 activity assay does not require a wash step, and thus, caspase activity is not lost due to cell lysis.
For experiments measuring bacterial effects on caspase activity, washed bacteria were incubated in RPMI plus heat-inactivated autologous serum (serum-HI) for 2 h in order to allow ACT secretion (44) . During incubation of bacteria, neutrophils were added to experimental wells, followed by addition of interleukin-8 (IL-8) (10 nM [RϩD Systems]) (45) . Bacteria and neutrophils (multiplicity of infection [MOI], 10:1) were then centrifuged together at 600 ϫ g for 5 min, and caspase 3/7 activity was measured after 4 h. TUNEL assay. For the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, neutrophils (2 ϫ 10 6 ) were incubated with toxin for 20 h at 37°C in 5% CO 2 . The percentage of cells undergoing DNA fragmentation was measured using the apo-bromodeoxyuridine (Apo-BrdU) kit (BD Pharmingen) according to the manufacturer's instructions. Briefly, toxin-treated neutrophils were incubated with BrdUTP in the presence of TdT enzyme in order to incorporate Br-dUTP into exposed 3=-OH DNA ends. Br-dUTP sites are detected with a fluorescein isothiocyanate (FITC)-labeled anti-BrdU monoclonal antibody (MAb). Stained cells were analyzed by flow cytometry using an excitation wavelength of 488 and emission at 530 with a FACSCalibur benchtop analyzer and Flowjo software.
Fluorescence microscopy. Assays with bacteria and neutrophils were performed in black-walled, 96-well, clear-bottom, tissue culture-treated plates in parallel with caspase 3/7 activity assays. In the case of PMAtreated neutrophils, cells were plated into glass-bottom, 12-well plates (Mattek). For live-cell imaging, DNA stains (2.5 M SYTOX green and 1 g/ml Hoechst 33342 [Life Sciences]) were added 30 min prior to imaging on an Olympus IX71 inverted fluorescence microscope fitted with a Qcolor3 camera and Q-Capture software. Channels were merged for insets (see Fig. 6 and 8) using Adobe Photoshop. Adjustments to brightness or contrast were performed on the whole image. For counting of cells forming neutrophil extracellular traps, 10ϫ or 20ϫ images were counted for total cell number and chromatin using the cell counter plugin on ImageJ. For all counting, the entire field of each image was counted from at least 3 independent experiments.
After live-cell imaging, paraformaldehyde (4% final concentration [Electron Microscopy Sciences]) was added to each well of the PMAtreated neutrophil plates. Cells were gently washed with phosphate-buffered saline (PBS), permeabilized with 0.2% Triton X-100, and immunostained. Primary antibodies included rabbit anti-histone H3 (Cell Signaling) and mouse anti-human neutrophil elastase (AHN-10 [Millipore]). Secondary Alexa Fluor-conjugated goat antibodies were provided by Molecular Probes. Images were acquired using a Zeiss LSM700 laser scanning confocal microscope, and channels were merged using Zeiss Zen software.
Because the anti-histone H3 antibody reacts with H3 in NETs but only weakly with H3 in non-NET-forming (non-"NETting") neutrophil nuclei, we tested whether the permeabilization protocol was adequate by staining with mouse anti-pan-histone antigen antibody (H11-4 [Millipore]) and counterstaining for cytoplasmic myeloperoxidase with rabbit anti-myeloperoxidase (Dako). The pan-histone antibody brightly stained histones in nuclei of freshly isolated neutrophils, confirming that our protocol resulted in nuclear membrane permeability (images not shown).
Quantitation of neutrophil oxidative burst. A total of 2 ϫ 10 5 neutrophils were plated in a white-walled, clear-bottom, 96-well, tissue cul-ture-treated plate. Cells were treated with 1 M diphenyleneiodonium (DPI [Sigma-Aldrich]), forskolin-IBMX, or ACT, and incubated for 30 min at 37°C in 5% CO 2 . The oxidative burst stimulus and luminol (100 M [Sigma-Aldrich]) were added, and luminescence was measured on a Victor 3, multilabel counter (PerkinElmer) every 6 min for 1 h.
Plate assay for NET quantification. A total of 2 ϫ 10 5 neutrophils were plated in black-walled, clear-bottom, 96-well, tissue culture-treated plates. Treatments were added, and the mixtures were incubated for the indicated time at 37°C in 5% CO 2 . Thirty minutes prior to reading fluorescence on the Victor 3 multilabel counter, SYTOX green (2.5 M) was Intracellular cAMP and ATP assays. A total of 2 ϫ 10 5 neutrophils were plated in white-walled, clear-bottom, 96-well, tissue culture-treated plates. Treatments were added, and the mixture was incubated for the indicated time at 37°C in 5% CO 2 . For ATP measurement, cells were lysed, and ATP was measured by the CellTiter-Glo luminescent cell viability assay (Promega). For cAMP measurement, cells were lysed, and cAMP was measured by the Tropix enzyme-linked immunosorbent assay-based cAMP assay kit (Applied Biosystems).
J774 cytotoxicity assay. Cells of the J774A.1 (J774) murine macrophage cell line were cultured in Dulbecco's modified Eagle's medium with a high concentration of glucose (Gibco) plus 10% FBS-HI (Gibco) at 37°C in 5% CO 2 . J774 cells (30,000 in 100 l) were seeded in each well of a 96-well plate and allowed to attach overnight at 37°C with 5% CO 2 . ACT was incubated with serum samples for 10 min at 4°C and then added to the cells at a final concentration of 80 ng/ml with the serum sample at a 1:20 dilution. Cells were then incubated at 37°C for 2 h. The number of viable cells was determined using the CCK8 assay (Dojindo Laboratories), which measures the reduction of WST-8, a water-soluble tetrazolium salt, by dehydrogenases in viable cells. Results are reported as percentage of control cells: [(experimental -blank)/(control -blank)] ϫ 100.
Statistics. Statistical analysis was performed by Graphpad Prism software and Microsoft Excel. In experiments requiring multiple comparisons, one-way analysis of variance (ANOVA) with posttest calculation was performed. The type of posttest is reported in the figure legend. For pairwise comparisons, a two-tailed Student's t test was used. A P value of Ͻ0.05 was considered significant.
RESULTS
ACT inhibits neutrophil apoptosis. The effect of purified ACT on neutrophil viability had not been previously tested. ACT at 100 ng/ml induces apoptosis in 80% of macrophages by 2 h in a cAMP-dependent manner, and we asked whether it would produce similar results in neutrophils (11) . Since cAMP has been demonstrated to inhibit neutrophil apoptosis, however, the ultimate outcome was difficult to predict (46) . In these experiments, cell-impermeant DNA binding dyes (propidium iodide [PI] and SYTOX green) were used to measure cell membrane permeability, a common endpoint of multiple mechanisms of cell death in vitro. Apoptosis was measured by annexin V, caspase 3/7, and DNA fragmentation. In all experiments, we used up to 100 ng/ml of ACT, a concentration that has been shown to be relevant to infection with B. pertussis (44) . When neutrophils were exposed to ACT at 10, 30, and 100 ng/ml for 4 h, there was no increase in PI staining or annexin V positivity ( Fig. 1A and B ). In fact, there was a significant decrease in neutrophils undergoing apoptosis (as measured by annexin V) at all toxin concentrations compared to control neutrophils, in which constitutive apoptosis is occurring. Thus at concentrations up to 100 ng/ml, ACT does not kill neutrophils but inhibits constitutive apoptosis.
Neutrophil apoptosis has been shown to be inhibited by cAMP as well as lipopolysaccharide (LPS) (46, 47) , which is a component of recombinant ACT prepared from E. coli. In order to distinguish between these two possible mechanisms, we tested the isolated effect of cAMP on apoptosis using forskolin and 3-isobutyl-1-methylxanthine (IBMX). Forskolin generates cAMP by activation of native adenylyl cyclase, and IBMX prevents cAMP degradation by inhibition of phosphodiesterases. As expected, forskolin plus IBMX decreased constitutive apoptosis (Fig. 1A and B) . To determine if LPS contained in the recombinant ACT preparation plays a role in the observed suppression of apoptosis, we used catalytically inactive ACT (iACT). This construct is recombinant, containing LPS from E. coli, and retains all functions of ACT except for enzymatic activity, due to a dual-amino-acid insertion in the catalytic domain. Catalytically inactive ACT suppresses annexin V positivity equivalently to WT ACT ( Fig. 1A and B) . Like annexin V staining, caspase 3/7 activity is decreased by 10, 30, and 100 ng/ml of ACT, forskolin-IBMX, and 100 ng/ml of iACT (Fig. 1C) . In the case of caspase 3/7, there is a difference between iACT and forskolin-IBMX (and a difference between iACT and ACT), indicating that cAMP contributes significantly to inhibiting caspase 3/7 activity. Using the caspase 3/7 assay, the role for LPS was further explored by extracting LPS from iACT using isopropyl alcohol, which reduces LPS content by 116-fold without affecting other functions of ACT (42) . There is a significant reduction in the ability of iACT to inhibit apoptosis when LPS is removed (Fig. 1D) . Based on these concentration-response profiles, the 50% effective concentrations (EC 50 s) for inhibition of apoptosis by iACT and LPS-extracted iACT were calculated and revealed that LPS removal reduces iACT-elicited inhibition of apoptosis by 39-fold. Altogether, these data indicate that both cAMP and LPS contribute to suppression of apoptosis by recombinant ACT.
We next tested the effect of ACT on the late marker of apoptosis, DNA fragmentation, measured by TUNEL staining. Treatment of neutrophils with ACT or iACT inhibits DNA fragmentation at 20 h in comparison to that in control neutrophils ( Fig. 2A ). These findings with the TUNEL assay agree with a 20-h time point of annexin V staining, showing again that ACT decreases apoptosis without increasing permeability based on PI staining (Fig. 2B to   D) . Thus, suppression of neutrophil apoptosis by recombinant ACT is reflected by early and late markers of apoptosis.
While it is apparent that ACT does not kill neutrophils under the tested conditions, E. coli LPS in the recombinant toxin preparation confounds the interpretation of these apoptosis assays; to better understand the relevance of ACT in inhibiting apoptosis, we tested apoptosis of neutrophils exposed to B. pertussis cells that secrete ACT. Prior to combination of bacteria and neutrophils, washed bacteria were incubated in medium for 2 h, during which time 25 to 30 ng/ml ACT has accumulated in the medium (44) . After combination, bacteria continue to secrete ACT. In addition, for these experiments, bacteria and neutrophils were centrifuged into apposition, which increases the effective concentration of the freshly secreted ACT by ϳ4-fold (44). To better model in vivo conditions, neutrophils were treated with 10 nM IL-8, a factor secreted by the host in response to B. pertussis (48, 49) , and then combined with B. pertussis. At this concentration, IL-8 had no effect on caspase 3/7 activity (data not shown).
Neutrophils exposed to ACT-negative (ACT neg ) B. pertussis (BP348), deficient in ACT expression due to transposon insertion in the cyaA gene (36), exhibited elevated caspase 3/7 activity compared to neutrophils not exposed to any bacteria (Fig. 3) . When neutrophils were exposed to ACT pos B. pertussis (wild-type strain BP338), caspase 3/7 activity was significantly decreased in comparison to that of both untreated and ACT neg BP348-treated neutrophils. To determine the role of cAMP generated by B. pertussissecreted ACT, we incubated ACT pos BP338 with a mouse monoclonal antibody, 3D1, that prevents translocation of the ACT catalytic domain, thereby precluding cAMP accumulation without blocking ACT binding to cells (40) . Addition of 3D1 blocked the inhibition of caspase 3/7 activity by BP338 (Fig. 3) , returning caspase 3/7 activity to the level observed in control neutrophils (P Ͼ 0.05 compared to control), although not to the level caspase 3/7 activity. B. pertussis organisms were grown as described in Materials and Methods, washed, resuspended at 2 ϫ 10 7 /ml, and incubated in RPMI plus autologous serum-HI for 2 h before being added to freshly isolated neutrophils (plated in the presence of 10 nM IL-8), at an MOI of 10:1. Antibodies at 100 g/ml (mouse IgG and MAb 3D1) were added to bacteria for 10 min at 37°C prior to being added to neutrophils. ACT, 100 ng/ml, was added to neutrophils immediately before bacteria. Bacteria and neutrophils were then centrifuged together at 600 ϫ g for 5 min and incubated at 37°C at 5% CO 2 . Caspase 3/7 activity was measured at 4 h and is shown as a percentage of that of control cells. The data are presented as means Ϯ SEM from 3 independent experiments (2 for antibody conditions) each performed in triplicate. *, P Ͻ 0.05 by ANOVA with Tukey's posttest. NS, not significant. in neutrophils treated with BP348. These data indicate that cAMP generated by B. pertussis-secreted ACT inhibits caspase 3/7 activity in the presence of whole B. pertussis.
B. pertussis-induced NETs are inhibited by ACT. As part of the caspase studies shown in Fig. 3 , we observed cells by fluorescence microscopy in the presence of the DNA-binding dye SYTOX green in order to monitor cell morphology and viability. Unexpectedly, neutrophils treated with ACT neg BP348 showed frequent fluorescent structures consistent with well-hydrated, neutrophil extracellular traps (NETs), whereas few NETs were seen in fields of neutrophils treated with ACT pos BP338 (Fig. 4A ). Neutrophils that were not exposed to bacteria remained spread with almost no NETted cells (i.e., the concentration of IL-8 used was 10-fold lower than that used to stimulate NETs [26] ), and addition of recombinant ACT to neutrophils in the presence of ACT neg BP348 suppressed NET formation. B. pertussis-induced NETs formed over the course of hours, which suggested an NADPH oxidase-dependent mechanism of NET formation rather than the more rapid NADPH oxidase-independent mechanism (28, 29, 50) . We, therefore, tested the dependence of B. pertussisinduced NET formation on the NADPH oxidase complex by incubation with diphenyleneiodonium (DPI), an NADPH oxidase inhibitor. As expected, DPI inhibited B. pertussis-induced NET formation. NETs were counted and expressed as a percentage of the total number of cells (Fig. 4B) . The percentage of NET formation induced by ACT neg BP348 at 3 h was 7.9% Ϯ 1.0% (mean Ϯ standard error of the mean [SEM]), but only 1.3% Ϯ 0.9% was induced by ACT pos BP338. ACT neg BP348 was significantly different from all of the other conditions tested. We also counted the neutrophils that were permeable, or nonviable, but not forming NETs based on bright, dense staining with SYTOX green (Fig. 4C) . While the data suggested that ACT neg BP348 increased the percentage of permeable neutrophils, there was no statistically significant difference in percentage of permeable cells among any of the conditions. In summary, ACT not only suppresses caspase 3/7 activity but also reduces B. pertussis-induced NET formation, and the induction of NETs by B. pertussis is dependent on NADPH oxidase activity.
ACT inhibits the neutrophil oxidative burst. Since B. pertussis-induced NET formation depends on assembly of the NADPH oxidase complex, the most likely explanation for inhibition of NET formation by ACT was the known inhibition of the oxidative burst by ACT. We, therefore, tested whether B. pertussis without ACT expression stimulates an oxidative burst and whether ACT suppresses this B. pertussis-induced oxidative burst. In fact, ACT neg BP348 induces a neutrophil oxidative burst and the oxidative burst induced by ACT pos BP338 is substantially lower (Fig.  5A ). Exogenous addition of recombinant ACT (100 ng/ml) suppresses the oxidative burst induced by ACT neg BP348. Likewise, DPI inhibits the B. pertussis-induced oxidative burst. Shown for comparison is the oxidative burst induced by PMA (Fig. 5B) , which is effectively inhibited by DPI. ACT, on the other hand, is less effective at inhibiting the PMA-induced oxidative burst, consistent with the lower efficacy of cAMP-elevating agents at inhibiting the PMA-induced oxidative burst in comparison to the oxidative response to receptor-mediated stimuli (51) . Forskolin and IBMX are also shown as an additional example of cAMP-mediated inhibition of the PMA-induced oxidative burst. Catalytically inactive ACT does not inhibit the PMA-induced oxidative burst (data not shown).
ACT inhibits phorbol ester-generated NETs. Because PMA stimulates an oxidative burst that is inhibited by ACT, and PMA elicits NADPH oxidase-dependent NETs (28), we asked whether ACT would inhibit PMA-induced NETs. Neutrophils respond to PMA with a stereotypical sequence of mixing of granular contents with nuclear contents, chromatin decondensation, nuclear dismantling, and ejection of the chromatin and granule mix into the extracellular space to form NETs (52, 53) . Ultimately, PMA-induced NET formation results in neutrophil lysis (NETosis) (27) . As an initial experiment to determine whether ACT inhibits PMAinduced NETs, neutrophils were observed by live-cell, wide-field microscopy in the presence of the cell-permeant DNA dye Hoechst 33342 and the cell-impermeant dye SYTOX green (Fig.  6 ). Hoechst 33342 stains the nuclei of healthy, unstimulated cells as small, bright, and multilobulated. Three hours after 20 nM PMA treatment, bright-field images show that cells have become flat and vacuolated, and Hoechst 33342 staining has become dimmer due to decondensation of chromatin. PMA is a soluble stimulus, and while there is some variability in the progression of cells toward NETosis, all cells are affected. At 3 h, many cells have released DNA, which appears as SYTOX green positive, and the region of positivity is larger than the bright-field cell footprint. As the chromatin complex spreads, a mature NET is formed. Treatment of neutrophils with 100 ng/ml ACT for 30 min prior to addition of PMA inhibits NET formation, with maintenance of chromatin condensation. Neutrophils treated with DPI plus PMA appear similar to those treated with ACT plus PMA, in that the neutrophil chromatin remains condensed. Catalytically inactive ACT (iACT) does not inhibit NET formation, indicating that catalytic activity is required for inhibition of NETosis. In summary, ACT prevents PMA-induced NET formation in a manner dependent on catalytic activity and with a morphology grossly similar to that resulting from inhibition by the NADPH oxidase inhibitor DPI.
In order to more fully characterize the morphology of the observed NET formation and inhibition by ACT, we employed immunostaining. NETs consist of chromatin interlaced with certain neutrophil proteins (26, 54) , and the DNA structures coimmunostain with histones and granule markers. In untreated cells, the granule marker neutrophil elastase remains separate from Hoechst 33342 stain (Fig. 7) . Following addition of PMA, the antihistone H3 antibody detects histone H3 antigen in structures consistent with NETs, which also contain neutrophil elastase and DNA. Brinkmann et al. have previously reported that antihistone antibodies may react with antigens strongly only after NET formation when chromatin is relaxed and not in the condensed neutrophil nucleus (55) , and this is the case with the anti-histone H3 antibody used here. When treated with ACT prior to PMA, neutrophils maintain a condensed nucleus, distinct from cytoplasmic granules, which remain intact and in high abundance. DPI also inhibits PMA-induced NET formation with morphological results similar to those from treatment with ACT. Based on morphology, treatment of neutrophils with ACT before PMA blocks NET formation at a stage prior to granule enzyme entry into the nucleus or chromatin decondensation, consistent with inhibition of the oxidative burst. Quantitation of NET formation and inhibition by cAMP. Having found that ACT inhibits NET formation, we next sought to quantify the effect of ACT in order to better understand the mechanism of inhibition. We used two complementary methods performed in parallel with each other-a fluorimetric plate assay, and a microscopy-based cell-counting assay. In the plate assay, PMA induces a time-dependent rise in SYTOX green positivity, which corresponds to the release of NETs as observed by microscopy. At 100 ng/ml, ACT reduces NETosis by 88% Ϯ 6.0% (mean Ϯ SEM) at 3 h and 51.6% Ϯ 3.9% at 4 h (Fig. 8A) . In order to quantify the effect of ACT over the time course of NET formation, we calculated the integrals (area under the curve [AUC]) of the curves shown in Fig. 8A , and 100 ng/ml ACT reduces PMAinduced NETosis 69.0%, based on the AUC. These values are similar to the inhibition of the PMA-induced oxidative burst at 1 h by 100 ng/ml ACT (51.2% Ϯ 1.7%), with a reduction in AUC of 66.0% (Fig. 5B) . Consistent with microscopy, neither 100 ng/ml ACT nor DPI alone elicits NETs (P Ͼ 0.05 at all time points) (Fig. 8B) . Inhibition of NET formation by ACT is concentration dependent, and forskolin-IBMX also inhibits NET formation with approximate equivalence to 10 ng/ml ACT (Fig. 8C) . As the second method for quantification of NET formation, the percentage of cells forming NETs was determined by assessing nuclear morphology in live-cell images (Fig. 8D ). In agreement with data derived from the 96-well plate-based assay, this image analysis showed that ACT results in concentration-dependent suppression of NETosis and that forskolin plus IBMX results in suppression of NETosis similar to that imposed by ACT at a concentration of 10 ng/ml.
Concentration-dependent inhibition of NET formation by ACT could be attributable to cAMP elevation or ATP depletion since ATP is consumed by ACT; however, we have found that forskolin-IBMX does not deplete ATP. At 10 ng/ml, ACT reduces ATP levels by 25% Ϯ 1.5% (mean Ϯ SEM), and at 30 ng/ml, it reduces them by 51% Ϯ 0.5% (Fig. 8E) . On the other hand, the combination of forskolin plus IBMX raises cAMP to levels similar to those with 10 to 30 ng/ml of ACT without any concomitant ATP depletion. In summary, these experiments have demonstrated that NET inhibition is concentration dependent and that cAMP elevation is sufficient for inhibition of NETs since forskolin and IBMX raise cAMP without depleting ATP. Because cAMP elevation inhibits the oxidative burst, and because NET formation by both PMA and B. pertussis is dependent on the oxidative burst, the studies suggest that cAMPmediated inhibition of the oxidative burst is responsible for NET inhibition by ACT.
Convalescent-phase sera from humans with pertussis block ACT-mediated inhibition of the oxidative burst, NETosis. Having characterized the ability of ACT to inhibit neutrophil apoptosis and NETosis, we asked whether antibodies generated after infection with B. pertussis (56) neutralize these novel effects of the toxin on neutrophils. We first screened convalescent-phase sera from patients with pertussis by testing for the serum's ability to neutralize ACT-mediated cytotoxicity in J774 macrophage cells (Fig. 9A) . Serum samples P1 and P2 most effectively inhibited cytotoxicity caused by recombinant ACT. "Control serum" was from subjects who had not had pertussis but who had been previously vaccinated with acellular pertussis vaccine (which does not contain ACT epitopes). As expected, control serum possessed no anti-ACT activity in the J774 assay. Based on the results of the J774 assay, we per- formed further testing in neutrophils with convalescent-phase specimens P1 and P2, in addition to control serum A. As a positive control for inhibition of ACT activity, we used MAb 3D1, as described above (Fig. 3) . Unlike 3D1 which blocks ACT-mediated inhibition of apoptosis by BP338 (Fig. 3) , convalescent-phase antisera P1 and P2 did not block inhibition of apoptosis induced by BP338 (data not shown); however, MAb 3D1, P1, and P2 all blocked ACT-mediated inhibition of the PMA-induced oxidative burst (Fig. 9B) , PMA-induced NETosis (Fig. 9C) , and wild-type B. pertussis-induced NET formation (Fig. 9D) . The percentage of NET formation stimulated by ACT pos BP338 (wild type) in the presence of MAb 3D1 was comparable to that induced by ACT neg BP348 (Fig. 4) . In sum, convalescent-phase antisera from patients with pertussis neutralize ACT's ability to inhibit the oxidative burst and NET formation.
DISCUSSION
NET formation was originally described as a form of cell death, distinct from and even mechanistically opposing apoptosis (28, 57, 58) . Here, we have found that, when mixed with neutrophils in vitro, ACT neg B. pertussis increases both caspase 3/7 activity and NET formation, but this does not necessarily imply a mechanistic link between these two neutrophil processes. Rather, the increase in both activities is likely attributable to a mixed population of neutrophils. The increase in apoptosis seen with neutrophils exposed to ACT neg B. pertussis may be attributable to phagocytosisinduced apoptosis in some cells in the population, which is more likely when neutrophils are in close proximity to bacteria. Our protocol of centrifugation increases the likelihood of phagocytosis but also enhances the inhibitory activity of ACT (59) . Within the same experiment, some cells are undergoing NET formation in response to ACT neg BP348 with a frequency of ϳ8% (Fig. 4) , a percentage similar to that induced by other bacteria and patho- gen-associated molecular patterns (55) . Thus, the sum of multiple factors, including ACT secretion and bacterial proximity, contributes to the fate of the neutrophils in the population. Multiple findings indicate that ACT inhibits NETosis by inhibiting the oxidative burst. ACT inhibits the B. pertussis-induced oxidative burst and B. pertussis-induced NETs, which are dependent on NADPH oxidase complex assembly. This dependence on the NADPH oxidase complex has been described for other Gramnegative pathogens as well (60) . Likewise ACT inhibits the PMAinduced oxidative burst and PMA-induced NETs, which are dependent on reactive oxygen species (ROS) (28) . Blocking ACT with MAb 3D1 or patient sera prevents inhibition of the oxidative burst as well as inhibition of NETosis. The amount of inhibition (based on AUC) of the PMA-induced oxidative burst by ACT is comparable to the amount of inhibition of NETosis. The morphology of neutrophils treated with ACT prior to PMA indicates an arrest in the phase of NETosis prior to fusions of granules with the nucleus. This morphology with condensed nuclei is similar to that seen when neutrophils are treated with DPI or inhibitors of the Raf-MEK-extracellular signal-regulated kinase (ERK) pathway prior to PMA (61) , and ACT-elicited cAMP is a known inhibitor of ERK phosphorylation (62) . In neutrophils, ERK phosphorylation is upstream of the oxidative burst in the sequence leading to PMA-induced NETosis (61) . Altogether, our findings indicate that ACT-mediated oxidative burst suppression inhibits NETs.
Our data also address other potential mechanisms by which ACT could be inhibiting NETs. A nuclease could break down NETs after formation, but our microscopy studies show inhibition by ACT prior to chromatin decondensation. In addition, iACT has no effect on NETs. Free radical scavengers may reduce ROS-induced NET formation, but neither iACT nor 3D1-treated ACT reduces NET formation. It is still possible that ACT has an inhibitory effect on NET formation downstream of oxidative signaling, in addition to its inhibition of the oxidative burst, since cAMP has broad-ranging signaling effects.
Although it was known prior to these studies that crude extracts of ACT inhibited the oxidative burst of neutrophils, ACT had not been tested for inhibition of NET formation, and ACT's effect on NETosis was not fully predictable. LPS associates with ACT, and LPS may induce NETs (26) . The homologous RTX toxin of Mannheimia haemolytica (Ltx), which does not make cAMP, induces NETosis (63). Malachowa et al. have suggested that NETs may be triggered by "nonspecific" cytolysis (64)-perhaps the mechanism of Ltx-induced NETosis. While many bacterial products have been shown to stimulate NETs, and on the other hand, some break down NETs after production (65) (66) (67) , ACT is the first toxin identified to prevent NET formation.
We have found that the antibody response to ACT after infection with B. pertussis can neutralize the effect of ACT on neutrophils. Mobberley-Schuman et al. have previously shown that a convalescent-phase antibody response can promote neutrophil phagocytosis of B. pertussis by neutralizing ACT-mediated inhibition of phagocytosis (56) . In these studies, 24/51 samples contained antibodies to ACT, but only 1/51 possessed activity that neutralized the antiphagocytic activity of ACT. We found that not all convalescent-phase samples inhibited ACT-mediated effects (Fig. 9A ). In addition, we found that P1, P2, and 3D1 all were highly effective at blocking ACT-mediated inhibition of NET formation, but all were less effective at blocking the antiapoptotic effect of ACT. We hypothesize that the relative effectiveness of these convalescent-phase sera at blocking NETs compared with apoptosis is attributable to the finding that NETs are inhibited by ACT-generated cAMP, whereas apoptosis is inhibited by cAMP, LPS, and potentially other factors.
The implications of the antiserum findings should be considered in light of the limited data regarding the interaction between ACT and neutrophils in vivo. Andreasen et al. have found that ACT suppresses the neutrophil-mediated clearance of B. pertussis from mice with prior immunity to B. pertussis (68) . In addition, ACT expression results in massive neutrophilic infiltration into the lungs of Bordetella bronchiseptica-infected mice (69) . Finally, Guierard et al. describe a lack of effect of ACT on neutrophil apoptosis in bronchoalveolar lavage (BAL) fluid (70) . Based on our data showing inhibition of both apoptosis and NETosis by ACT, we propose that ACT promotes neutrophilic infiltrates by inhibiting neutrophil death. Because ACT may be an important and immunogenic component of future acellular pertussis vaccines, the potential functional consequences of anti-ACT antibodies should be considered. For example, it is interesting that both 3D1 and convalescent-phase serum were more effective at neutralizing NET inhibition than apoptosis. This suggests that some antibodies to ACT may result in greater neutrophil accumulation and NETting in vivo. While allowing apoptosis seems intuitively beneficial to the host, it is, as yet, unclear what the role of NETs is in vivo. NETs can be directly cytotoxic, and accumulation of NETs plays a role in the chronic lung disease cystic fibrosis as well as other inflammatory diseases (32, 34) . To gain a complete picture of the balance between pathogen defense and host damage during pertussis, the contribution of NETs to clearance of B. pertussis in vivo will need to be assessed. The data presented here should alert investigators to the ability for ACT and antibodies to ACT to dysregulate neutrophil death mechanisms and potentially influence local tissue damage during infection with B. pertussis.
